Clinical Trial Update: Trivalent Chromium Treatment for Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluating trivalent chromium for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Trivalent chromium (trivalent chromium)

Snippet

Sponsor: Alexandria University | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED